InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,307.25
(
0.10%
)
Post# of 4972675
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Ask kicker

Send PM Follow Ignore
Followers 60
Posts 5882
Boards Moderated 0
Alias Born 07/17/2009

Ask kicker

Re: None

Tuesday, 05/26/2015 10:07:33 PM

Tuesday, May 26, 2015 10:07:33 PM

Post# of 4972675
OXiGENE Gets U.S. Patent for Myeloid Neoplasms Treatment - Jumping 7% in After-Hours
BY Midnight Trader
— 4:10 PM ET 05/26/2015

04:10 PM EDT, 05/26/2015 (MT Newswires) -- OXiGENE ( OXGN) , a biopharmaceutical company developing novel therapies for the treatment of cancer, today said the U.S. Patent and Trademark Office has granted it a patent (U.S. Patent No. 9,040,500) related to the use of OXi4503 for the treatment of myeloid neoplasms, including acute myeloid leukemia (AML).

Price: 1.49, Change: +0.10, Percent Change: +7.1


Need a good stock tip? Check out my jonecool Wiki page, right here on iHub with DD and more!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up